Episode Details
Back to Episodes
Global Eye Health 2026: Tackling Glaucoma Disparities
Description
This audio article is from VisualFieldTest.com.
Read the full article here: https://visualfieldtest.com/en/global-eye-health-2026-tackling-glaucoma-disparities
Test your visual field online: https://visualfieldtest.com
Support the show so new episodes keep coming: https://www.buzzsprout.com/2563091/support
Excerpt:
Global Eye Health 2026: Tackling Glaucoma Disparities Evidence reviewed through June 30, 2026 Glaucoma is often called a “silent thief of sight” because it can damage the optic nerve for years before a person notices a problem. Once vision is lost, it usually cannot be restored. However, early detection, pressure-lowering treatment, laser therapy, and surgery can often slow or stop further damage. The global glaucoma challenge is therefore not simply a lack of effective treatments. It is a problem of late detection, unequal access, medicine cost, weak referral systems, limited surgical capacity, and difficulty maintaining lifelong care. These problems are most severe in low-resource settings, rural communities, and groups facing financial or gender-related barriers. The global glaucoma burden in 2026 There is no single real-time worldwide glaucoma census. Different studies measure different outcomes: Total glaucoma disease includes people with early disease who may have no symptoms. Glaucoma-related blindness counts people whose glaucoma has caused profound vision loss. Disability-adjusted life years measure the combined effect of disability and premature loss of healthy life. These measures should not be treated as interchangeable. For the full table, please open this article on visualfieldtest.com. The long-standing global projection of 76 million people with glaucoma in 2020 and 111.8 million by 2040 comes from a systematic review of population eye studies. The 2024 global analysis of glaucoma-related vision loss estimated 3.61 million people were blind and 4.14 million had moderate-to-severe vision impairment because of glaucoma in 2020. () A study published online in June 2026 using Global Burden of Disease 2021 data found that the absolute number of modelled glaucoma cases increased by approximately 86% between 1990 and 2021, even though age-standardised prevalence and disability-adjusted life-year rates declined. Population growth and ageing explain much of this apparent contradiction: the risk at a given age may be falling, but more people are reaching the ages when glaucoma becomes common. () Regional disparities are marked Sub-Saharan Africa: high disease burden and late presentation Sub-Saharan Africa continues to experience the highest age-standardised burden of glaucoma-related blindness and moderate-to-severe vision impairment. In the 2020 global analysis, the age-standardised prevalence of glaucoma-related blindness among people aged 50 years and older was approximately 0.66% in Sub-Saharan Africa, compared with 0.20% globally. The region also had the highest age-standardised prevalence of glaucoma-related moderate-to-severe vision impairment. () A 2025 systematic review and Bayesian meta-analysis estimated glaucoma prevalence in Africa at 5.59%, with primary open-angle glaucoma accounting for approximately 5.07%. The pooled prevalence was highest in Southern Africa and lowest in East Africa, although the authors noted substantial variation between countries and studies. () Nigeria illustrates the scale of the problem. A national population survey estimated glaucoma prevalence at approximately 5.02% among people aged 40 years and older. In clinical and outreach settings, many people present after substantial damage has already occurred. These findings should not be interpreted as evidence that every Nigerian patient is diagnosed late,